tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
United Therapeutics price target raised to $600 from $580 at UBS
PremiumThe FlyUnited Therapeutics price target raised to $600 from $580 at UBS
3M ago
United Therapeutics announces first clinical xenotransplantation in EXPAND study
Premium
The Fly
United Therapeutics announces first clinical xenotransplantation in EXPAND study
4M ago
United Therapeutics price target raised to $587 from $569 at RBC Capital
Premium
The Fly
United Therapeutics price target raised to $587 from $569 at RBC Capital
4M ago
United Therapeutics Corp’s Earnings Call Highlights Growth and Innovation
PremiumCompany AnnouncementsUnited Therapeutics Corp’s Earnings Call Highlights Growth and Innovation
4M ago
Strong Growth Potential and Strategic Initiatives Drive Buy Rating for United Therapeutics
Premium
Ratings
Strong Growth Potential and Strategic Initiatives Drive Buy Rating for United Therapeutics
4M ago
United Therapeutics price target raised to $575 from $564 at Jefferies
Premium
The Fly
United Therapeutics price target raised to $575 from $564 at Jefferies
4M ago
United Therapeutics’ Promising Study on Inhaled Treprostinil for Lung Disease
PremiumCompany AnnouncementsUnited Therapeutics’ Promising Study on Inhaled Treprostinil for Lung Disease
4M ago
United Therapeutics’ Promising Phase 3 Study on Inhaled Treprostinil for Pulmonary Fibrosis
Premium
Company Announcements
United Therapeutics’ Promising Phase 3 Study on Inhaled Treprostinil for Pulmonary Fibrosis
4M ago
United Therapeutics’ AI-Driven Study: A Potential Game-Changer for Pulmonary Hypertension Diagnosis
Premium
Company Announcements
United Therapeutics’ AI-Driven Study: A Potential Game-Changer for Pulmonary Hypertension Diagnosis
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100